[Developing process of guide on methodological standards in pharmacoepidemiology (T/CPHARMA 002-2019)]

Area of Science:

• Pharmacoepidemiology
• Drug safety and efficacy evaluation
• Public health research methodology

Background:

• Pharmacoepidemiology utilizes epidemiological methods to assess drug use and outcomes in large populations.
• Standardized research methodologies are essential for reliable pharmacoepidemiological studies.
• Existing national and international standards require adaptation to specific healthcare practices.

Purpose of the Study:

• To develop a standardized methodological guideline for pharmacoepidemiology research in China.
• To provide a practical reference for regulatory agencies, research institutions, and pharmaceutical manufacturers.
• To enhance the quality and consistency of drug safety and efficacy evaluations.

Main Methods:

• Systematic review of existing national and international pharmacoepidemiological standards and guidelines.
• Integration of Chinese medical and health practices.
• Incorporation of expert opinions from the Professional Committee of Pharmacoepidemiology.

Main Results:

• Development of the group standard "Guide on Methodological Standards in Pharmacoepidemiology" (T/CPHARMA 002-2019).
• Establishment of a comprehensive guide tailored to the Chinese context.
• Creation of a standardized framework for conducting pharmacoepidemiological research.

Conclusions:

• The newly developed guideline provides essential direction for pharmacoepidemiology research in China.
• Standardization improves the evaluation of drug safety and efficacy.
• The guideline supports evidence-based decision-making in pharmaceutical regulation and practice.